Medicine
Lorazepam 2 mg tablet
Lorazepam 2 mg tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° - 25° C (68° - 77° F).
Key facts
- Active ingredient (INN)
- Lorazepam
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 10 tablets and 97 more
- Manufacturers
- Aurolife PharmaIndiaSun Pharmaceutical IndustriesIndiaAphena Pharma Solutions - TennesseeANI PharmaceuticalsLeading PharmaRising Pharma HoldingsTeva PharmaceuticalsChartwell RX19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° - 25° C (68° - 77° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05BA06 Lorazepam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 October 1987
- Identifiers
- RxCUI 197902, 197900, 197901DailyMed set ID 1bcf608a-11c1-ec7d-e063-6394a90ab710, 1f79a5a1-0c40-45cf-8994-51f5ba3a5938, 551a1b7f-d342-2c53-e063-6394a90a9a2a +27NDC 71610-842, 72789-376, 87441-051 +27Application ANDA076045, ANDA072928, ANDA203572 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 100 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 13107-085-01 | Aurolife PharmaIndia | 1 February 2021 |
| 500 tablet in 1 bottle | 13107-085-05 | Aurolife PharmaIndia | 1 February 2021 |
| 10 tablet in 1 bottle | 13107-085-10 | Aurolife PharmaIndia | 1 February 2021 |
| 1000 tablet in 1 bottle | 13107-085-99 | Aurolife PharmaIndia | 1 February 2021 |
| 100 tablet in 1 bottle | 63304-774-01 | Sun Pharmaceutical IndustriesIndia | 25 June 2023 |
| 500 tablet in 1 bottle | 63304-774-05 | Sun Pharmaceutical IndustriesIndia | 25 June 2023 |
| 1000 tablet in 1 bottle | 63304-774-10 | Sun Pharmaceutical IndustriesIndia | 25 June 2023 |
| 90 tablet in 1 bottle | 63304-774-90 | Sun Pharmaceutical IndustriesIndia | 25 June 2023 |
| 100 tablet in 1 bottle | 62559-197-01 | ANI Pharmaceuticals | 1 December 2024 |
| 500 tablet in 1 bottle | 62559-197-05 | ANI Pharmaceuticals | 1 December 2024 |
| 1000 tablet in 1 bottle | 62559-197-10 | ANI Pharmaceuticals | 1 December 2024 |
| 100 tablet in 1 bottle | 62135-863-01 | Chartwell RX | 6 November 2024 |
| 100 tablet in 1 bottle | 69315-906-01 | Leading Pharma | 16 May 2023 |
| 500 tablet in 1 bottle | 69315-906-05 | Leading Pharma | 16 May 2023 |
| 1000 tablet in 1 bottle | 69315-906-10 | Leading Pharma | 16 May 2023 |
| 100 tablet in 1 bottle | 64980-629-01 | Rising Pharma Holdings | 24 July 2025 |
| 1000 tablet in 1 bottle | 64980-629-10 | Rising Pharma Holdings | 24 July 2025 |
| 500 tablet in 1 bottle | 64980-629-50 | Rising Pharma Holdings | 24 July 2025 |
| 100 tablet in 1 bottle, plastic | 0093-3427-01 | Teva Pharmaceuticals | 20 July 2021 |
| 500 tablet in 1 bottle, plastic | 0093-3427-05 | Teva Pharmaceuticals | 20 July 2021 |
| 1000 tablet in 1 bottle, plastic | 0093-3427-10 | Teva Pharmaceuticals | 20 July 2021 |
| 15 tablet in 1 bottle | 71610-178-15 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 30 tablet in 1 bottle | 71610-178-30 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 45 tablet in 1 bottle | 71610-178-45 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 60 tablet in 1 bottle | 71610-178-53 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 90 tablet in 1 bottle | 71610-178-60 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 120 tablet in 1 bottle | 71610-178-70 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 180 tablet in 1 bottle | 71610-178-80 | Aphena Pharma Solutions - Tennessee | 24 October 2018 |
| 30 tablet in 1 bottle | 71610-600-30 | Aphena Pharma Solutions - Tennessee | 29 September 2021 |
| 60 tablet in 1 bottle | 71610-600-53 | Aphena Pharma Solutions - Tennessee | 21 September 2021 |
| 90 tablet in 1 bottle | 71610-600-60 | Aphena Pharma Solutions - Tennessee | 21 September 2021 |
| 120 tablet in 1 bottle | 71610-600-70 | Aphena Pharma Solutions - Tennessee | 21 September 2021 |
| 15 tablet in 1 bottle, plastic | 71610-655-15 | Aphena Pharma Solutions - Tennessee | 23 November 2022 |
| 30 tablet in 1 bottle, plastic | 71610-655-30 | Aphena Pharma Solutions - Tennessee | 1 August 2022 |
| 45 tablet in 1 bottle, plastic | 71610-655-45 | Aphena Pharma Solutions - Tennessee | 23 November 2022 |
| 60 tablet in 1 bottle, plastic | 71610-655-53 | Aphena Pharma Solutions - Tennessee | 1 August 2022 |
| 90 tablet in 1 bottle, plastic | 71610-655-60 | Aphena Pharma Solutions - Tennessee | 1 August 2022 |
| 120 tablet in 1 bottle, plastic | 71610-655-70 | Aphena Pharma Solutions - Tennessee | 1 August 2022 |
| 180 tablet in 1 bottle, plastic | 71610-655-80 | Aphena Pharma Solutions - Tennessee | 23 November 2022 |
| 30 tablet in 1 bottle | 71610-768-30 | Aphena Pharma Solutions - Tennessee | 5 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 September 1977 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lorazepam 2 mg tablet.
Other strengths and forms of Lorazepam
Clinical summary
Lorazepam is a benzodiazepine indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. MedsAcross supplies Lorazepam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LorazepamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ativan prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Lorazepam 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.